SynthesisLeukemia2023

Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Arend V Stackelberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.